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Introduction 
Endothelial-derived nitric oxide (NO) is essential in the regulation of diastolic blood 
pressure and promotes an antithrombotic surface which attenuates leukocyte-
endothelial interactions associated with vascular injury. Endothelial nitric oxide 
synthase (eNOS) produces NO from L-arginine in the presence of the essential cofactor 
tetrahydrobiopterin (BH4) (Fig. 1). When BH4 is oxidized to dihydrobiopterin (BH2) 
during vascular injury the ratio of BH2/BH4 is increased and this promotes eNOS to 
produce superoxide (SO) instead of NO and is termed eNOS uncoupling (1). Our 
previous studies have shown administration of BH2 promotes leukocyte-endothelial 
interactions (Fig. 2) in the mesenteric circulation in vivo. The pro-inflammatory effects 
of BH2 may be due to the increased BH2/BH4  ratio causing eNOS uncoupling and 
reduced endothelial-derived NO bioavailability (2). Protein kinase C epsilon (PKC ε) 
activates eNOS via phosphorylation on eNOS serine 1177 using PKC ε peptide activator  
(PKC ε+). Whereas, PKC ε peptide inhibitor ( PKC ε-) reduces eNOS activity (3) (Fig. 3). 
However, the effect of PKC ε+ peptide or PKC ε- to exacerbate or attenuate BH2-induced 
leukocyte-endothelial interactions has not yet been determined.  
Methods 
Conclusions 
We predict that BH2 with the addition of PKC ε- (N-Myr-EAVSLKPT, MW=1054, Genemed 
Synthesis, Inc., San Antonio, TX) will inhibit uncoupled eNOS, increase endothelial-
derived NO bioavailability and reduce endothelial-leukocyte interactions. By contrast, 
when the PKC ε+ (N-Myr-HDAPIGYD, MW=1097, Genemed Synthesis) is administered 
with BH2, it will augment uncoupled eNOS activity and/or sustain the BH2-induced 
leukocyte-endothelial interactions. However, when the BH4/BH2 ratio is increased and 
the coupled eNOS status is more favorable, we predict that the addition of PKC ε+, will 
promote NO release from eNOS and attenuate the BH2 induced inflammation. Whereas, 
PKC ε- will attenuate BH2 induced inflammation even in the presence of increased BH4 . 
We found that BH2  significantly increased leukocyte rolling, adherence, and 
transmigration when compared to Krebs’ control ( P<0.05 ), and this effect was similar 
with BH2 + PKC ε+ ( P<0.05). Whereas, BH2 + PKC ε-  (P<0.01) significantly attenuated all 
three types of BH2-induced inflammation . The data suggest that eNOS uncoupling may 
be an important mechanism mediating inflammation-induced vascular injury, and  that 
inhibiting uncoupled eNOS activity with PKC ε- may attenuate oxidative stress and restore 
vascular endothelial function. However, we found that BH4 + PKC ε+ significantly reduced 
BH2 -induced inflammation. This data suggest that PKC  ε+ can exert anti-inflammatory 
effects when  the BH4/BH2 ratio is increased to promote eNOS coupling. This study 
outlines the importance that the BH2/BH4 ratio determines whether eNOS is in the 
uncoupled or coupled state.  Moreover, inhibiting uncoupled eNOS activity with PKC ε- or 
increasing coupled eNOS activity with PKC ε+ can both exert anti-inflammatory effects. 
This idea provides indirect evidence as a potential strategy for attenuating endothelial 
dysfunction-induced inflammatory responses in various vascular diseases.   
Results 
Figure 2. Leukocyte-endothelial interaction cascade in the basement membrane of 
blood vessel that begins with initial leukocytes rolling and concluding with extravasation 
through the vascular endothelial cells. Attenuation of this process reduces 
inflammation-mediated tissue damage.  
Figure 1. A. In healthy vascular endothelium, there is an increased BH4 to BH2  ratio. BH4 
binds to the ferrous-dioxygen domain complex in the oxygenase domain which results in 
a coupling reduction of molecular O2 to L-arginine oxidation and synthesizes NO. B. In 
diseased conditions, BH4 is limited and becomes oxidized to BH2 increasing the BH2/BH4 
ratio to promote uncoupled eNOS. The electron transfer is uncoupled from L-arginine, 
the ferrous-dioxygen complex dissociates, and SO is produced from the oxygenase 
domain from molecular oxygen (1).  
Intravital microscopy was performed on one loop of mesentery of male Sprague-Dawley 
rats (275-325 g, Ace Animals, Boyertown, PA) and the mesentery was placed on a viewing 
pedestal to observe mesenteric venules under light microscopy (Fig. 4). A right carotid 
artery cannulation was performed to monitor mean arterial blood pressure. During the 
experiment, test solutions ( listed in the following experimental groups) were superfused 
over the mesentery and the number of rolling (number that passed a set reference point 
per minute), adhered (number that remained firmly adhered to the endothelial surface 
for >30 seconds within 100 µm length), and transmigrated (number that had emigrated 
through the endothelium within 10 µm on either side of the 100 µm length of venule) 
leukocytes were recorded (4).  
Figure 6. Leukocyte adherence among different experimental groups. 100 µM BH2 and 
100 µM BH2 + 10 µM PKC ε+ significantly increased leukocyte adherence (**P<0.01 from 
Krebs’) . The effect of BH2 was significantly attenuated by the addition of 10µM PKC ε-, 
100 µM BH4 + 10 µM PKC ε-, and 100 µM BH4 + PKC ε+ (##P<0.01 from 100 µM BH2).  
 
Figure 4. Experimental setup for intravital 
microscopy. Inserted picture in upper right: 
exteriorized loop of mesenteric tissue 
undergoing superfusion of test solution.  
Hypothesis 
Figure 3. Hypothesis diagram of PKC ε+/PKC ε- combined with BH4/BH2 on vascular 
endothelial function and leukocyte-endothelial interactions. 
 
Experimental Groups 
1. Control: superfusion of Krebs’ 
buffer (n=4) 
2. BH2: superfusion of 100 µM BH2 
(n=5)  
3. BH2 + PKC ε+: superfusion of 100 
µM BH2 + 10 µM PKC ε+ (n=6)  
4. BH2 + PKC ε-: superfusion of 100 
µM BH2 + 10 µM PKC ε- (n=5)  
5. BH2 + BH4: superfusion of 100 µM 
BH2 / 100 µM BH4 (n=5) 
6. BH2 + BH4 + PKC ε+: superfusion 
of 100 µM BH2/100 µBH4 + 10 µM 
PKC ε+ (n=5) 
7. BH2 +BH4 + PKC ε-: superfusion of 
100 µM BH2/100 µMBH4 + PKC ε- 
(n=5) 
 
 
 
 
 
Figure 5. Leukocyte rolling among different experimental groups. 100 µM BH2 and 100 
µM BH2 + 10 µM PKC ε+ significantly increased leukocyte rolling (**P<0.01 from Krebs’) . 
The effect of  BH2 was significantly attenuated by the addition of 10µM PKC ε-, 100 µM 
BH4 + 10 µM PKC ε-, and 100 µM BH4 + PKC ε+ (##P<0.01 from 100 µM BH2). 
Figure 7. Leukocyte transmigration among different experimental groups. 100 µM BH2 
and 100 µM BH2 + 10 µM PKC ε+ significantly increased leukocyte transmigration 
(*P<0.05, **P<0.01 from Krebs’) . The effect of BH2 was significantly attenuated by the 
addition of 10µM PKC ε-, 100 µM BH4 + 10 µM PKC ε-, and 100 µM BH4 + PKC ε+ (# 
P<0.05, ##P<0.01 from 100 µM BH2).  
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